Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 32 entries
Sorted by: Best Match Show Resources per page
International Federation of Clinical Chemistry (IFCC): Scientific Division, Committee on Apolipoproteins; Working Group of Antibody Reagents: Selection and Characterization of Monoclonal Antibodies for Measuring Plasma Levels of Apolipoproteins A-I and B.

The Journal of automatic chemistry

Marcovina S, Curtiss LK, Milne R, Albers JJ.
PMID: 18925274
J Automat Chem. 1990;12(5):195-8. doi: 10.1155/S1463924690000256.

No abstract available.

Cite
Marcovina S, Curtiss LK, Milne R, et al. International Federation of Clinical Chemistry (IFCC): Scientific Division, Committee on Apolipoproteins; Working Group of Antibody Reagents: Selection and Characterization of Monoclonal Antibodies for Measuring Plasma Levels of Apolipoproteins A-I and B. J Automat Chem. 1990;12(5):195-8doi: 10.1155/S1463924690000256.
Marcovina, S., Curtiss, L. K., Milne, R., & Albers, J. J. (1990). International Federation of Clinical Chemistry (IFCC): Scientific Division, Committee on Apolipoproteins; Working Group of Antibody Reagents: Selection and Characterization of Monoclonal Antibodies for Measuring Plasma Levels of Apolipoproteins A-I and B. The Journal of automatic chemistry, 12(5), 195-8. https://doi.org/10.1155/S1463924690000256
Marcovina, S, et al. "International Federation of Clinical Chemistry (IFCC): Scientific Division, Committee on Apolipoproteins; Working Group of Antibody Reagents: Selection and Characterization of Monoclonal Antibodies for Measuring Plasma Levels of Apolipoproteins A-I and B." The Journal of automatic chemistry vol. 12,5 (1990): 195-8. doi: https://doi.org/10.1155/S1463924690000256
Marcovina S, Curtiss LK, Milne R, Albers JJ. International Federation of Clinical Chemistry (IFCC): Scientific Division, Committee on Apolipoproteins; Working Group of Antibody Reagents: Selection and Characterization of Monoclonal Antibodies for Measuring Plasma Levels of Apolipoproteins A-I and B. J Automat Chem. 1990;12(5):195-8. doi: 10.1155/S1463924690000256. PMID: 18925274; PMCID: PMC2547832.
Copy Download .nbib Format: NLM
Proteins related to lipoprotein profile were identified using a pharmaco-proteomic approach as markers for growth response to growth hormone (GH) treatment in short prepubertal children.

Proteome science

Andersson B, Hellgren G, Nierop AF, Hochberg Z, Albertsson-Wikland K.
PMID: 19883510
Proteome Sci. 2009 Nov 02;7:40. doi: 10.1186/1477-5956-7-40.

BACKGROUND: The broad range in growth observed in response to growth hormone (GH) treatment is mainly caused by individual variations in both GH secretion and GH sensitivity. Individual GH responsiveness can be estimated using evidence-based models that predict the...

Cite
Andersson B, Hellgren G, Nierop AF, et al. Proteins related to lipoprotein profile were identified using a pharmaco-proteomic approach as markers for growth response to growth hormone (GH) treatment in short prepubertal children. Proteome Sci. 2009;7:40doi: 10.1186/1477-5956-7-40.
Andersson, B., Hellgren, G., Nierop, A. F., Hochberg, Z., & Albertsson-Wikland, K. (2009). Proteins related to lipoprotein profile were identified using a pharmaco-proteomic approach as markers for growth response to growth hormone (GH) treatment in short prepubertal children. Proteome science, 740. https://doi.org/10.1186/1477-5956-7-40
Andersson, Björn, et al. "Proteins related to lipoprotein profile were identified using a pharmaco-proteomic approach as markers for growth response to growth hormone (GH) treatment in short prepubertal children." Proteome science vol. 7 (2009): 40. doi: https://doi.org/10.1186/1477-5956-7-40
Andersson B, Hellgren G, Nierop AF, Hochberg Z, Albertsson-Wikland K. Proteins related to lipoprotein profile were identified using a pharmaco-proteomic approach as markers for growth response to growth hormone (GH) treatment in short prepubertal children. Proteome Sci. 2009 Nov 02;7:40. doi: 10.1186/1477-5956-7-40. PMID: 19883510; PMCID: PMC2777859.
Copy Download .nbib Format: NLM
Cardiovascular risk factors in portuguese obese children and adolescents: impact of small reductions in body mass index imposed by lifestyle modifications.

The open biochemistry journal

Nascimento H, Costa E, Rocha-Pereira P, Rego C, Mansilha HF, Quintanilha A, Santos-Silva A, Belo L.
PMID: 22629286
Open Biochem J. 2012;6:43-50. doi: 10.2174/1874091X01206010043. Epub 2012 May 11.

OBJECTIVES: Evaluate cardiovascular risk factors in Portuguese obese children and adolescents and the long-term effects of lifestyle modifications on such risk factors.DESIGN: Transversal cohort study and longitudinal study.SETTING: University Hospital S. João and Children's Hospital Maria Pia, Porto.PATIENTS/PARTICIPANTS: 148...

Cite
Nascimento H, Costa E, Rocha-Pereira P, et al. Cardiovascular risk factors in portuguese obese children and adolescents: impact of small reductions in body mass index imposed by lifestyle modifications. Open Biochem J. 2012;6:43-50doi: 10.2174/1874091X01206010043.
Nascimento, H., Costa, E., Rocha-Pereira, P., Rego, C., Mansilha, H. F., Quintanilha, A., Santos-Silva, A., & Belo, L. (2012). Cardiovascular risk factors in portuguese obese children and adolescents: impact of small reductions in body mass index imposed by lifestyle modifications. The open biochemistry journal, 643-50. https://doi.org/10.2174/1874091X01206010043
Nascimento, Henrique, et al. "Cardiovascular risk factors in portuguese obese children and adolescents: impact of small reductions in body mass index imposed by lifestyle modifications." The open biochemistry journal vol. 6 (2012): 43-50. doi: https://doi.org/10.2174/1874091X01206010043
Nascimento H, Costa E, Rocha-Pereira P, Rego C, Mansilha HF, Quintanilha A, Santos-Silva A, Belo L. Cardiovascular risk factors in portuguese obese children and adolescents: impact of small reductions in body mass index imposed by lifestyle modifications. Open Biochem J. 2012;6:43-50. doi: 10.2174/1874091X01206010043. Epub 2012 May 11. PMID: 22629286; PMCID: PMC3358715.
Copy Download .nbib Format: NLM
Plasma apolipoproteins A-I, A-II, B, C-II, C-III, and E levels in young Kuwaiti male survivors of myocardial infarction.

Annals of Saudi medicine

Al-Muhtaseb N, Al-Yousuf AR.
PMID: 17589176
Ann Saudi Med. 1992 May;12(3):252-8. doi: 10.5144/0256-4947.1992.252.

Plasm levels of lipid, lipoprotein, and apolipoprotein (APO) A-I, A-II, C-II, C-III, and E were analyzed in 180 young survivors of myocardial infarction (MI) ages 28 to 45 years and in 200 sex-and age-matched normal healthy subjects to assess...

Cite
Al-Muhtaseb N, Al-Yousuf AR. Plasma apolipoproteins A-I, A-II, B, C-II, C-III, and E levels in young Kuwaiti male survivors of myocardial infarction. Ann Saudi Med. 1992;12(3):252-8doi: 10.5144/0256-4947.1992.252.
Al-Muhtaseb, N., & Al-Yousuf, A. R. (1992). Plasma apolipoproteins A-I, A-II, B, C-II, C-III, and E levels in young Kuwaiti male survivors of myocardial infarction. Annals of Saudi medicine, 12(3), 252-8. https://doi.org/10.5144/0256-4947.1992.252
Al-Muhtaseb, N, and Al-Yousuf, A R. "Plasma apolipoproteins A-I, A-II, B, C-II, C-III, and E levels in young Kuwaiti male survivors of myocardial infarction." Annals of Saudi medicine vol. 12,3 (1992): 252-8. doi: https://doi.org/10.5144/0256-4947.1992.252
Al-Muhtaseb N, Al-Yousuf AR. Plasma apolipoproteins A-I, A-II, B, C-II, C-III, and E levels in young Kuwaiti male survivors of myocardial infarction. Ann Saudi Med. 1992 May;12(3):252-8. doi: 10.5144/0256-4947.1992.252. PMID: 17589176.
Copy Download .nbib Format: NLM
The way of serum chromium utilization may contribute to cardiovascular risk factors in centrally obese persons.

Archives of medical science : AMS

Wysocka E, Cymerys M, Mielcarz G, Bryl W, Dzięgielewska S, Torliński L.
PMID: 22291765
Arch Med Sci. 2011 Apr;7(2):257-63. doi: 10.5114/aoms.2011.22076. Epub 2011 May 17.

INTRODUCTION: Obesity-related disturbances are considered to be risk factors for cardiovascular disease (CVD). Chromium is shown to improve carbohydrate and lipid metabolism. Conflicting data on effects of chromium supplementation in humans are published. The aim of the study was...

Cite
Wysocka E, Cymerys M, Mielcarz G, et al. The way of serum chromium utilization may contribute to cardiovascular risk factors in centrally obese persons. Arch Med Sci. 2011;7(2):257-63doi: 10.5114/aoms.2011.22076.
Wysocka, E., Cymerys, M., Mielcarz, G., Bryl, W., Dzięgielewska, S., & Torliński, L. (2011). The way of serum chromium utilization may contribute to cardiovascular risk factors in centrally obese persons. Archives of medical science : AMS, 7(2), 257-63. https://doi.org/10.5114/aoms.2011.22076
Wysocka, Ewa, et al. "The way of serum chromium utilization may contribute to cardiovascular risk factors in centrally obese persons." Archives of medical science : AMS vol. 7,2 (2011): 257-63. doi: https://doi.org/10.5114/aoms.2011.22076
Wysocka E, Cymerys M, Mielcarz G, Bryl W, Dzięgielewska S, Torliński L. The way of serum chromium utilization may contribute to cardiovascular risk factors in centrally obese persons. Arch Med Sci. 2011 Apr;7(2):257-63. doi: 10.5114/aoms.2011.22076. Epub 2011 May 17. PMID: 22291765; PMCID: PMC3258713.
Copy Download .nbib Format: NLM
Efficacy and safety of ezetimibe/simvastatin co- administered with fenofibrate in mixed hyperlipidemic patients with metabolic syndrome.

Metabolic syndrome and related disorders

Gil-Extremera B, Mendez G, Zakson M, Meehan A, Shah A, Lin J, Mitchel Y.
PMID: 18370800
Metab Syndr Relat Disord. 2007 Dec;5(4):305-14. doi: 10.1089/met.2007.0011.

BACKGROUND: We compared the lipid-altering effects of ezetimibe/simvastatin (EZE/SIMVA) co-administered with fenofibrate (FENO) in mixed hyperlipidemic patients with (MetS) versus those without MetS.METHODS: A total of 611 patients, 20 to 79 years old, with LDL-C 130-220 mg/dL (100-180 mg/dL...

Cite
Gil-Extremera B, Mendez G, Zakson M, et al. Efficacy and safety of ezetimibe/simvastatin co- administered with fenofibrate in mixed hyperlipidemic patients with metabolic syndrome. Metab Syndr Relat Disord. 2007;5(4):305-14doi: 10.1089/met.2007.0011.
Gil-Extremera, B., Mendez, G., Zakson, M., Meehan, A., Shah, A., Lin, J., & Mitchel, Y. (2007). Efficacy and safety of ezetimibe/simvastatin co- administered with fenofibrate in mixed hyperlipidemic patients with metabolic syndrome. Metabolic syndrome and related disorders, 5(4), 305-14. https://doi.org/10.1089/met.2007.0011
Gil-Extremera, Blas, et al. "Efficacy and safety of ezetimibe/simvastatin co- administered with fenofibrate in mixed hyperlipidemic patients with metabolic syndrome." Metabolic syndrome and related disorders vol. 5,4 (2007): 305-14. doi: https://doi.org/10.1089/met.2007.0011
Gil-Extremera B, Mendez G, Zakson M, Meehan A, Shah A, Lin J, Mitchel Y. Efficacy and safety of ezetimibe/simvastatin co- administered with fenofibrate in mixed hyperlipidemic patients with metabolic syndrome. Metab Syndr Relat Disord. 2007 Dec;5(4):305-14. doi: 10.1089/met.2007.0011. PMID: 18370800.
Copy Download .nbib Format: NLM
The relation between dietary intake of vegetable oils and serum lipids and apolipoprotein levels in central Iran.

ARYA atherosclerosis

Boroujeni HK, Sarrsfzadegan N, Mohammadifard N, Sajjadi F, Asgary S, Maghroon M, Alikhassi H, Esmailzaded A.
PMID: 23205051
ARYA Atheroscler. 2012;7(4):168-75.

BACKGROUND: The detrimental effects of partially hydrogenated vegetable oils (PHVOs) on apolipoproteins have been reported from several parts of the world. However, little data is available in this regard from the understudied region of the Middle East. The present...

Cite
Boroujeni HK, Sarrsfzadegan N, Mohammadifard N, et al. The relation between dietary intake of vegetable oils and serum lipids and apolipoprotein levels in central Iran. ARYA Atheroscler. 2012;7(4):168-75
Boroujeni, H. K., Sarrsfzadegan, N., Mohammadifard, N., Sajjadi, F., Asgary, S., Maghroon, M., Alikhassi, H., & Esmailzaded, A. (2012). The relation between dietary intake of vegetable oils and serum lipids and apolipoprotein levels in central Iran. ARYA atherosclerosis, 7(4), 168-75.
Boroujeni, Hossein Khosravi, et al. "The relation between dietary intake of vegetable oils and serum lipids and apolipoprotein levels in central Iran." ARYA atherosclerosis vol. 7,4 (2012): 168-75.
Boroujeni HK, Sarrsfzadegan N, Mohammadifard N, Sajjadi F, Asgary S, Maghroon M, Alikhassi H, Esmailzaded A. The relation between dietary intake of vegetable oils and serum lipids and apolipoprotein levels in central Iran. ARYA Atheroscler. 2012;7(4):168-75. PMID: 23205051; PMCID: PMC3413086.
Copy Download .nbib Format: NLM
Plasma triglyceride-rich lipoprotein remnants as a risk factor of 'Pokkuri disease'.

Legal medicine (Tokyo, Japan)

Takeichi S, Nakajima Y, Yukawa N, Saito T, Seto Y, Huang XL, Kusakabe T, Jin ZB, Hasegawa I, Nakano T, Saniabadi A, Adachi M, Ohara N, Wang T, Nakajima K.
PMID: 12935528
Leg Med (Tokyo). 2001 Jun;3(2):84-94. doi: 10.1016/s1344-6223(01)00010-4.

In our recent report, it remained unclear whether or not triglyceride-rich lipoprotein remnants (RLP) were associated with the risk of sudden coronary death in younger cases without coronary atherosclerosis that were detected in about 10% of all sudden coronary...

Cite
Takeichi S, Nakajima Y, Yukawa N, et al. Plasma triglyceride-rich lipoprotein remnants as a risk factor of 'Pokkuri disease'. Leg Med (Tokyo). 2001;3(2):84-94doi: 10.1016/s1344-6223(01)00010-4.
Takeichi, S., Nakajima, Y., Yukawa, N., Saito, T., Seto, Y., Huang, X. L., Kusakabe, T., Jin, Z. B., Hasegawa, I., Nakano, T., Saniabadi, A., Adachi, M., Ohara, N., Wang, T., & Nakajima, K. (2001). Plasma triglyceride-rich lipoprotein remnants as a risk factor of 'Pokkuri disease'. Legal medicine (Tokyo, Japan), 3(2), 84-94. https://doi.org/10.1016/s1344-6223(01)00010-4
Takeichi, S, et al. "Plasma triglyceride-rich lipoprotein remnants as a risk factor of 'Pokkuri disease'." Legal medicine (Tokyo, Japan) vol. 3,2 (2001): 84-94. doi: https://doi.org/10.1016/s1344-6223(01)00010-4
Takeichi S, Nakajima Y, Yukawa N, Saito T, Seto Y, Huang XL, Kusakabe T, Jin ZB, Hasegawa I, Nakano T, Saniabadi A, Adachi M, Ohara N, Wang T, Nakajima K. Plasma triglyceride-rich lipoprotein remnants as a risk factor of 'Pokkuri disease'. Leg Med (Tokyo). 2001 Jun;3(2):84-94. doi: 10.1016/s1344-6223(01)00010-4. PMID: 12935528.
Copy Download .nbib Format: NLM
Birth weight, cord blood lipoprotein and apolipoprotein levels in Indian newborns.

International journal of preventive medicine

Kharb S, Kaur R, Singh V, Sangwan K.
PMID: 21677763
Int J Prev Med. 2010;1(1):29-33.

OBJECTIVES: Primordial prevention of chronic disease is of clinical and public health importance. Considering the fetal onset of atherosclerosis, we aimed to determine the cord blood level of lipoproteins and apolipoproteins as well as their correlation with birth weight...

Cite
Kharb S, Kaur R, Singh V, et al. Birth weight, cord blood lipoprotein and apolipoprotein levels in Indian newborns. Int J Prev Med. 2010;1(1):29-33
Kharb, S., Kaur, R., Singh, V., & Sangwan, K. (2010). Birth weight, cord blood lipoprotein and apolipoprotein levels in Indian newborns. International journal of preventive medicine, 1(1), 29-33.
Kharb, Simmi, et al. "Birth weight, cord blood lipoprotein and apolipoprotein levels in Indian newborns." International journal of preventive medicine vol. 1,1 (2010): 29-33.
Kharb S, Kaur R, Singh V, Sangwan K. Birth weight, cord blood lipoprotein and apolipoprotein levels in Indian newborns. Int J Prev Med. 2010;1(1):29-33. PMID: 21677763; PMCID: PMC3075485.
Copy Download .nbib Format: NLM
Increased Binding of Apolipoproteins A-I and E4 to Triglyceride-Rich Lipoproteins is linked to Induction of Hypertriglyceridemia.

JSM atherosclerosis

Gorshkova IN, Atkinson D.
PMID: 28597004
JSM Atheroscler. 2017;2(2). Epub 2017 Feb 13.

Hypertriglyceridemia (HTG) is an independent factor of atherosclerotic cardiovascular disease and a hallmark of many metabolic disorders. However, the molecular etiology of HTG is still largely unknown. In mice, severe HTG may be induced by expression of specific mutants...

Cite
Gorshkova IN, Atkinson D. Increased Binding of Apolipoproteins A-I and E4 to Triglyceride-Rich Lipoproteins is linked to Induction of Hypertriglyceridemia. JSM Atheroscler. 2017;2(2)
Gorshkova, I. N., & Atkinson, D. (2017). Increased Binding of Apolipoproteins A-I and E4 to Triglyceride-Rich Lipoproteins is linked to Induction of Hypertriglyceridemia. JSM atherosclerosis, 2(2), .
Gorshkova, Irina N, and Atkinson, David. "Increased Binding of Apolipoproteins A-I and E4 to Triglyceride-Rich Lipoproteins is linked to Induction of Hypertriglyceridemia." JSM atherosclerosis vol. 2,2 (2017).
Gorshkova IN, Atkinson D. Increased Binding of Apolipoproteins A-I and E4 to Triglyceride-Rich Lipoproteins is linked to Induction of Hypertriglyceridemia. JSM Atheroscler. 2017;2(2). Epub 2017 Feb 13. PMID: 28597004; PMCID: PMC5460632.
Copy Download .nbib Format: NLM
Tel-Aviv-Heidelberg Three Generation Offspring Study: Genetic and environmental sources of variation and covariation among plasma lipids, lipoproteins, and apoliproteins.

American journal of human biology : the official journal of the Human Biology Council

Livshits G, Vainder M, Graff E, Blettner M, Schettler G, Brunner D.
PMID: 28561298
Am J Hum Biol. 1997;9(3):357-370. doi: 10.1002/(SICI)1520-6300(1997)9:3<357::AID-AJHB8>3.0.CO;2-V.

Multivariate genetic analysis, implemented in the statistical package for pedigree analysis, FISHER, was carried out on a large sample of Israeli pedigrees to evaluate heritability and genetic correlations among an array of plasma lipids: total cholesterol (TCHL), triglycerides (TRIG),...

Cite
Livshits G, Vainder M, Graff E, et al. Tel-Aviv-Heidelberg Three Generation Offspring Study: Genetic and environmental sources of variation and covariation among plasma lipids, lipoproteins, and apoliproteins. Am J Hum Biol. 1997;9(3):357-370doi: 10.1002/(SICI)1520-6300(1997)9:3<357::AID-AJHB8>3.0.CO;2-V.
Livshits, G., Vainder, M., Graff, E., Blettner, M., Schettler, G., & Brunner, D. (1997). Tel-Aviv-Heidelberg Three Generation Offspring Study: Genetic and environmental sources of variation and covariation among plasma lipids, lipoproteins, and apoliproteins. American journal of human biology : the official journal of the Human Biology Council, 9(3), 357-370. https://doi.org/10.1002/(SICI)1520-6300(1997)9:3<357::AID-AJHB8>3.0.CO;2-V
Livshits, G, et al. "Tel-Aviv-Heidelberg Three Generation Offspring Study: Genetic and environmental sources of variation and covariation among plasma lipids, lipoproteins, and apoliproteins." American journal of human biology : the official journal of the Human Biology Council vol. 9,3 (1997): 357-370. doi: https://doi.org/10.1002/(SICI)1520-6300(1997)9:3<357::AID-AJHB8>3.0.CO;2-V
Livshits G, Vainder M, Graff E, Blettner M, Schettler G, Brunner D. Tel-Aviv-Heidelberg Three Generation Offspring Study: Genetic and environmental sources of variation and covariation among plasma lipids, lipoproteins, and apoliproteins. Am J Hum Biol. 1997;9(3):357-370. doi: 10.1002/(SICI)1520-6300(1997)9:3<357::AID-AJHB8>3.0.CO;2-V. PMID: 28561298.
Copy Download .nbib Format: NLM
The effect of Macrotyloma uniflorum seed on bile lithogenicity against diet induced cholelithiasis on mice.

Ancient science of life

Bigoniya P, Bais S, Sirohi B.
PMID: 25593405
Anc Sci Life. 2014 Apr-Jun;33(4):242-51. doi: 10.4103/0257-7941.147433.

BACKGROUND: The seeds of Macrotyloma uniflorum Lam. (Family Fabaceae) contain extractable total and tannins with reported hepatoprotective, hypocholesterolemic and antioxidant activity. In this study, dietary M. uniflorum seed, methanolic and acetone extracts (ME and AE) were examined for their...

Cite
Bigoniya P, Bais S, Sirohi B. The effect of Macrotyloma uniflorum seed on bile lithogenicity against diet induced cholelithiasis on mice. Anc Sci Life. 2014;33(4):242-51doi: 10.4103/0257-7941.147433.
Bigoniya, P., Bais, S., & Sirohi, B. (2014). The effect of Macrotyloma uniflorum seed on bile lithogenicity against diet induced cholelithiasis on mice. Ancient science of life, 33(4), 242-51. https://doi.org/10.4103/0257-7941.147433
Bigoniya, Papiya, et al. "The effect of Macrotyloma uniflorum seed on bile lithogenicity against diet induced cholelithiasis on mice." Ancient science of life vol. 33,4 (2014): 242-51. doi: https://doi.org/10.4103/0257-7941.147433
Bigoniya P, Bais S, Sirohi B. The effect of Macrotyloma uniflorum seed on bile lithogenicity against diet induced cholelithiasis on mice. Anc Sci Life. 2014 Apr-Jun;33(4):242-51. doi: 10.4103/0257-7941.147433. PMID: 25593405; PMCID: PMC4293752.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 32 entries